title: Haloemodins, a new class of endothelin-1 type B (ETB) receptor binding inhibitors.
authors.affiliation: Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492.
authors.forename: Y Z
authors.initials: YZ
authors.lastname: Shu
authors.forename: M
authors.initials: M
authors.lastname: Arcuri
authors.forename: M R
authors.initials: MR
authors.lastname: Kozlowski
authors.forename: R R
authors.initials: RR
authors.lastname: Wang
authors.forename: K S
authors.initials: KS
authors.lastname: Lam
authors.forename: L P
authors.initials: LP
authors.lastname: Chang
authors.forename: D M
authors.initials: DM
authors.lastname: Pirnik
authors.forename: P M
authors.initials: PM
authors.lastname: Rose
mesh_terms: D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D004642:Emodin / Q000031:analogs & derivatives / Q000494:pharmacology*; D065128:Endothelin Receptor Antagonists; D006801:Humans; D017466:Receptors, Endothelin / Q000502:physiology; D013329:Structure-Activity Relationship
chemical_list: D065128:Endothelin Receptor Antagonists; D017466:Receptors, Endothelin; D004642:Emodin